+ and -denote the presence or absence of clinical and laboratory findings of disease. a Results of 0-10 rain area insulin in mU. 1-1. min-1 according to [29] (normal range 200-1870 mU. 1-1. min-~)
tures [10] . Autoantibodies in sera of patients with APS I have been reported with reactivity against parathyroid glands [12] , adrenal cortex [12] , islets of Langerhans [2] , gastric parietal cells [2] and the thyroid gland [13, 14] . Although Type I diabetes is a condition previously reported to occur in only 4 % to 12 % of patients with APS I [9, 10] , Ahonen et al. [9] demonstrated that approximately 50 % of the patients will develop diabetes before the age of 50 years. Eisenbarth and Jackson [15] report that figures as low as 4 % to 12 9/0 are underestimations, due to the fact that most of the studies have been carried out on young patients with APS I.
In the present study, patients with APS I were investigated with respect to a humoral immune response against pancreatic islets, since the appearance of betacell damage apparently differs from that found in classic Type i diabetes. Evidence of a different antibody reactivity against GAD was obtained, and reactivity against a novel 51 kDa islet cell autoantigen was observed.
Subjects, materials and methods
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with stiff-man syndrome, and six healthy blood donors were employed. The NIMH-1440 antiserum raised in sheep against purified rat brain GAD was a gift from Dr. I. J. Kopin and co-workers [18] at the National Institute of Health (Bethesda, Md., USA). This antiserum reacts against the two known isoforms of GAD (GAD-65 and GAD-67), but exhibits preference for the low molecular weight isoform. A rabbit antiserum against porcine glucagon was purchased (Dako Corporation, Carpinteria, Calif., USA), as was a guinea pig antiserum against porcine insulin (Dako-immunoglobulins a/s, Glostrup, Denmark). A rabbit antiserum against rat carboxypeptidase-H [19] was a generous gift from Dr. R Guest at the Department of Clinical Biochemistry, University of Cambridge (Cambridge, UK). A rabbit antiserum (K2) against feline GAD-67 was a gift from Dr. A. Tobin, UCLA (Los Angeles, Calif., USA) [20] .
Imrnunohistochemistry
For immunoperoxidase staining, unfixed cryostat sections of Wistar-Furth rat pancreas and cerebellum were submitted to a mild fixation at + 4~ in 50 % acetone in water [volume/volume (v/v)] for 30 s and then in 100 % acetone for 5 min. After airdrying at room temperature the sections were rinsed in phosphate-buffered saline (PBS) composed of 137 mmol/1 NaC1, 2.7 mmol/1 KC1, 4.3 mmol/1 Na2HPO4 and 1.4 mmol/1 KH2PO4, pH 7.3 for 5 min, incubated in 0.3 % H202 in PBS for 15 min and again rinsed in PBS. Incubation with a normal rabbit serum for 5 rain at room temperature preceded the incubation with patient sera (in serial dilution), glucagon antiserum in a dilution of 1:75 or NIMH-1440 in 1:1,000 dilution for 24 h at + 4 ~ Following washings with PBS, each section was covered with a 1:200 dilution of peroxidase-conjugated rabbit anti-human or anti-sheep IgG antibody (Dako) and the incubations were continued for another 30 rain at room temperature. After washing, the chromogenic reaction was started by the addition of a mixture containing 10 mg 3-amino-9-ethylcarbazol dissolved in 6 ml dimethyl sulphoxide, 50 ml 0.02 mol/1 NaAc pH 5.5 and 4 g130% H202. The reaction was continued for 15 min at room temperature and stopped by rinsing in PBS. Counterstaining was performed with haematoxylin.
Immunofluorescence double staining was performed using cryostat sections of Wistar-Furth rat pancreas fixed in 1% (weight/volume) paraformaldehyde (Sigma Chemical Co., St. Louis, Mo., USA) in PBS. The primary antibody was glucagon antiserum which was detected using rodamine immunoglobulin-conjugate against rabbit IgG (Dako). The third antibody was either the APS I patient serum (tested in serial dilution) or the insulin antiserum, which were detected by fluorescein isothiocyanate (FITC) conjugated rabbit IgG against human IgG or guinea pig IgG, respectively. Analysis were performed using a Nikon Microphot FXA fluorescence microscope.
Patient sera and specific antisera
Sera from six patients with APS I, three females and three males, between 6 and 19 years of age, were used in the study. All patients had mucocutaneous candidiasis, three suffered from hypoparathyroidism, and five had adrenocortical insufficiency. None of the patients were diabetic at the time of serum collection ( Table 1) . Investigation of the insulin response to an intravenous glucose challenge was performed in all patients according to Bingley et al. [16] : Sera from nine patients With recent-onset Type 1 diabetes, all investigated for the presence of islet cell antibodies (ICA) [2] and GAD antibodies [17] , were used. Also, sera from seven patients with Addison's disease, five patients with Graves' disease, four patients with autoimmune gastritis, two patients
Isolation and culture of islets of Langerhans, RINm 5F cells and COS cells
Islets of Langerhans from Wistar-Furth rats were manually isolated after collagenase digestion [21] , and used either freshly after isolation or after free-floating culture for 48 h in RPMI medium (NordVacc, Skfirholmen, Sweden) containing 28 mmol/1 glucose and 10 % fetal calf serum. For immunoprecipitations, the islets were labelled with [35S]-methionine ( > 1,100 Ci/mmol, Amersham International, Bucks., UK) and lysed using a method previously described [22] . For use in Western blots islets were lysed without previous radiolabelling. The RINm 5F cell line [23] was cultivated in Ham F12 medium (NordVacc) sup- ). The GAD antiserum NIMH-1440 (A and A'), sera from APS I patient # 1 (B and B'), APS I patient # 3 (C and C'), and a healthy blood donor (D and D') were used. In pancreas, a positive staining of the islets is seen with the GAD antiserum NIMH-1440 and with both APS I patients (A, B and C). In the cerebellum, only GAD NIMH-1440 and APS I patient # 1 stain the neurons of the Purkinje and granular cell layer (A' and B'), whereas no staining is observed with APS I patient # 3 plemented with non-essential amino acids and 10% fetal calf serum. The SV-40 transformed, monkey kidney cell line COS [24] was cultivated in DMEM (NordVacc) with 10% fetal calf serum. As described for the islets of Langerhans [22] , the RINm 5F cells and the COS cells were either lvsed, or labelled with [35S]-methionine and lysed, for use in Western blots and immunoprecipitations, respectively.
Hornogenates from rat tissues
Brain, testes, small intestine, adrenals, spleen and exocrine pancreas of Wistar-Furth rats were homogenised in ice-cold 10 retool/1 Tris/C1 buffer, pH 7.4 containing, 0.25 mol/1 sucrose, I retool/1 EDTA and I mmolfl phenylmethyl sulphonylflnoride The pattern of staining with the patient serum is similar to that observed with GAD antiserum NIMH-1440, suggesting a betaceil restricted expression for the target antigen (PMSF) (homogenising buffer), using a syringe and a 20 gauge needle. Debris were removed by spinning the homogenates at 1,000 x g during 15 rain at + 4~ and the supernatants kept at -70 ~ for further use in Western blots.
Recombinant GAD
Recombinant rat GAD-65 and -67 were transiently expressed in a eukaryotic system (COS cells) as previously described [17] , and used either in immunoprecipitation experiments after labelling with [35S]-methionine, or in Western blot experiments.
Immunoprecipitations and Western blots
Gradient (10-15%) sodium dodecylsulphate polyacrylamide gels (SDS-PAGE) were assembled as previously described [25] . For immunoprecipitations, sera of patients, healthy blood donors and specific antisera were incubated with aliquots of the [35S]-methionine labelled lysates and the immune complexes formed were collected as described elsewhere [22] . Following electrophoresis, fixation of the gels was performed in a solution containing 10 % acetic acid and 30 % methanol in water (v/v) during i h. The gels were then incubated for 45 min in Enhance (DuPont, NEN Research Products, Boston, Mass., USA) and washed for 10 min in 2% glycerol in water (v/v). Gels were finally dried in a vacuum dryer at + 65 ~ 90 min and exposed for fluorography with Fuji RX films at -70 ~ For Western blots, SDS-PAGE were prepared following the same procedures [25] . Lysates of either islet cells, RINm 5F cells, COS cells or homogenates of the different rat tissues were quantitated for their total protein concentration using the BCA (bicinchoninic acid) protein assay method (Pierce Chemical Company, Rockford, Ill., USA). Samples containing similar amounts of total protein were suspended in a sample buffer consisting of 0.1 mol/1 Tris/C1, pH 8.8, 3 % SDS, 10 retool/1 dithiothreitol, 10 % sucrose and trace amounts of bromophenol blue and were heated for 3 rain at + 95~ After a short centrifugation at 10,000 • g, iodoacetamide was added to a final concentration of 50mmol/1. An incubation of 15 rain at room temperature preceded the loading onto the gel. For Western blots, proteins were transferred to a nitrocellulose membrane (Amersham International) after electrophoresis using a 200 mA current for 24 h, and the reactivity of sera examined as described [26] .
Ion-exchange chromatography
A DEAE-Sepharose (Pharmacia, Uppsala, Sweden) column (1 cm • 0.5 cm) was equilibrated with 10 volumes of 0.1 tool/1 Tris/C1, pH 8.2 (equilibration buffer 1) followed by 10 volumes of 20 retool/1 Tris/Cl pH 8.2, plus 0.1% Triton X-100 (Eastman Kodak Co., Rochester, NY, USA), 20 retool/1 PMSF and 1% Trasylol (Bayer, Leverkusen, Germany) (equilibration buffer 2).
[35S]-methionine lysates of islet or RINm 5F cells were applied to columns in aliquots of 0.2 column volumes. Washing was performed with 10 volumes of equilibration buffer 2. Three different elution buffers were used sequentially, the first containing 20 mmol/1 NaC1, the second containing 0.2 tool/1 NaC1 and the third containing 0.5 molfl NaC1, each prepared with the equilibration buffer 2. Fractions of 0.2 volumes were collected from the flow-through and from the different stepwise eluates and pooled according to the radioactive peaks counted in a LKB //-counter (LKB Scintillation Products, Bromma, Sweden). Pools were used in subsequent immunoprecipitation experiments. 
Lentil lectin chromatography
Results
Immunohistochemistry
In initial experiments sera from all six APS I patients were used in immunoperoxidase staining of frozen sections of pancreas and cerebellum. Serum from a patient with Type 1 diabetes known to be positive in islet staining and with strong reactivity against G A D was used in parallel. Also, the NIMH-1440 G A D antiserum and sera from two healthy blood donors were used. All six APS I sera stained strongly the islets of Langerhans, and all but one serum ( # 3) showed strong staining of the Purkinje and granular cells in the cerebellum (Fig. 1) . Comparative staining with a glucagon antiserum and the NIMH-1440 G A D antiserum were performed using sequential sections of frozen pancreas. The pattern of reactivity of sera from all APS I patients was similar to that observed with the NIMH-1440 G A D antiserum, i.e. restricted to the beta cells (Fig.2) . These observations were further confirmed by immunofluorescence double staining. The APS I patient sera reacted in a pattern similar to that observed with the insulin antiserum, but did not stain the glucagon containing cells (not shown). The lack of cerebellar staining with serum from patient # 3 indicated reactivity against an antigen different from GAD.
Immunoprecipitation of rat islet lysates
Immunoprecipitations using sera of six APS I patients were performed in parallel with the NIMH-1440 G A D antiserum, serum from a Type 1 diabetic patient known to react against GAD, and two healthy blood donors. Except for patient # 3, all sera from APS I patients precipitated a doublet in the 65-67 kDa range which co-migrated with G A D precipitated by the NIMH-1440 antiserum and by the serum of a patient with Type i diabetes (Fig.3) . Moreover, sera from all six APS I patients precipitated a band of 51 kDa which was not detectable in the immunoprecipitates of the other control sera (Fig. 3 ).
Western blots with tissue homogenates and cell lysates
To investigate the tissue distribution of the 51 kDa antigen, Western blot experiments were performed using homogenates from spleen, testes, adrenals, brain, exocrine pancreas and small intestine from Wistar-Furth rats. Also, lysates from a rat insulinoma cell line RINm 5F, which does not express GAD, and an SV-40 transformed, simian renal cell line COS, were used. The homogenates and cell line lysates were run in similar protein concentrations and in parallel with a rat islet lysate. Analysis of reactivity was performed using sera from all APS I patients and two healthy blood donors. All APS I patient sera recognized a 51 kDa band in islets of Langerhans and in RINm 5F cells, but not in any of the tissues tested or in the COS cells. In adrenals, reactivity against a protein migrating at 53 kDa and identical to the cytochrome P450 sidechain cleavage enzyme was observed [27] . In addition, all but one (patient # 3) of the APS I patients reacted against a protein of 64 kDa (supposedly G A D ) in the islet lysate and in the brain homogenate (data not shown).
Patients with other autoimrnune endocrine diseases
The reactivity against the 51 kDa islet antigen was tested using sera from patients, with autoimmune endocrine diseases and lysates of [35S]-methionine la- The arrows between lanes d and e indicate the positions of GAD (upper arrow) and the 51 kDa antigen (lower arrow). RINm 5F lysates were submitted to the same ion-exchange purification procedure and the fraction eluted with 0.2 mol/1 NaC1 was used for immunoprecipitations with sera from one patient with recent-onset Type i diabetes (lane e), six APS I.patients (lanes fto k), two patients with stiff-man syndrome (lanes 1 and m) , and a healthy blood donor (lane n). Molecular weight markers (MW) corresponding to 97.4kDa, 69kDa, 46kDa, 30kDa and 21.5 kDa are on the right margin. An arrow indicating the position of the 51 kDa antigen is between lanes d and e (lower arrow)
Biochemical characterization of the 51 k Da antigen
U p o n D E A E -S e p h a r o s e chromatography at p H 8,2, the 51 k D a protein was recovered in a fraction eluted with 0.2 mol/1 of NaC1 (Fig. 4) . The antigen did not appear to be glycated since it was not retarded on Lentil lectin-Sepharose 4B (data not shown). A 0.2 mol/1 NaC1 eluate from DEAE-Sepharose chromatography of a [35S]-methionine labelled R I N m 5F lysate was employed in immunoprecipitations with sera from the six APS I patients. A band of 51 kDa was regularly found whereas sera of patients with stiff-man syndrome or Type i diabetes did not precipitate such a protein (Fig. 4) . Immunoprecipitations of pS]-methionine labelled COS cell lysates with the six APS I patient sera did not identify any 51 kDa protein (data not shown).
Sequential immunoprecipitations for characterization of the 51 kDa antigen
belled R I N m 5F cells. Sera from seven patients with Addison's disease, five patients with Graves' disease, nine patients with Type 1 diabetes and four patients with autoimmune gastritis were tested in parallel with sera from six healthy blood donors and two APS I patients ( # 1 and # 3). Except for the APS I patient sera, no other serum showed reactivity against the 51 k D a antigen when the immunoprecipitates were analysed by SDS-PAGE and fluorography (not shown).
Carboxypeptidase-H, a 52 k D a enzyme involved in the processing of pro-insulin to insulin, present in the betacell secretory granule and reported to be a potential autoantigen in Type i diabetes [28] , was examined as a potential candidate for the novel 51 kD a antigen.
[35S]-methionine labelled rat islet lysates were used for sequential immunoprecipitation experiments in incubations with the polyclonal antisera against carboxypeptidase-H or G A D , followed by immunoprecipitations of the supernatant with the serum from APS I patient # 1. The immunoprecipitation of lysates with the carboxypeptidase-H antiserum did not suppress the capacity of the APS I patient serum to identify the 51 kDa protein. W h e n the pre-precipitation was per-formed using the NIMH-1440 G A D antiserum, the 51 kDa protein was unchanged and a weak band possibly corresponding to the 67 kDa isoform of GAD, appeared with reduced strength in the APS I immunoprecipitate (Fig. 5) . Thus, depletion of the G A D protein from the islet lysate did not affect the amount of 51 kDa antigen, demonstrating that the latter is unrelated to GAD.
67
APS I reactivity against the different isoforms of GAD
Reactivity against recombinant GAD-65 could be detected by immunoprecipitation and Western blot using sera from all but one (patient # 3) of the APS I patients (Fig. 6) . Patients # 1, # 2 and # 5 also recognized recombinant GAD-67 butwithlower capacity. Serum from a patient with stiff-man syndrome was analysed in parallel and reacted against both isoforms of G A D either byimmunoprecipitation or by Western blot (Fig. 6) .
Intravenous glucose tolerance test
First phase insulin release to a 0.5 g/kg glucose load was investigated in all APS I patients. As shown in Table 1 the insulin responses were in the normal range [29] in all subjects.
Discussion
In the present study, using sera from patients with APS I, we found a strong reactivity against G A D in five out of six sera examined, and discovered a novel islet autoantigen, a non-glycated protein of 51 kDa. Sera from patients with APS I reacted with G A D similarly to sera from patients with stiff-man syndrome, i. e. recognising the denatured and reduced protein in Western blots, while sera of diabetic patients do not [4] . Also, APS I sera stain islets in frozen sections of pancreas, or the Purkinje and granular cells in sections of cerebellum even at a dilution of more than 1:10,000, while sera from diabetic patients seldom stain at dilutions up to 1:2,000 (data not shown). Furthermore, most of the APS I sera react with both the 67 kDa and 65 kDa isoforms of GAD, albeit preferentially against GAD-65, whereas only few sera of diabetic patients recognize the 67 kDa isoform [17] .
Sera from all six APS I patients showed strong reactivity against a novel 51 kDa antigen when analysed both by immunoprecipitations and Western blots. Christie et al. [30] have described reactivity against a 50 kDa tryptic fragment of G A D as marker for development of diabetes in a study of identical twins. Using the NIMH-1440 G A D antiserum and performing sequential immunoprecipitation experiments, no relationship between the 51 kDa antigen recognized by the APS I patients and G A D was observed. Carboxypeptidase-H, a glycated protein of the betacell insulin secretory granule, has been reported to be an autoantigen recognized by antibodies in sera of prediabetic subjects [28] . Classically, carboxypeptidase-H is regarded as a 52 kDa protein [28] but a soluble form of 50 kDa [31] and an immature form of 57 kDa [19] have also been reported. With the use of a specific antiserum, Guest et al. [19] found by Western blots analysis of insulin granule preparations, a wide band spreading from 57 kDa to 53 kDa, probably corresponding to intermediary products between the immature and the soluble forms. Using the same antiserum and lysates of rat islets we performed sequential immunoprecipitation experiments with serum from an APS I patient. Although carboxypeptidase-H was seen as a wide band between 57 kDa and 53 kDa, serum against this enzyme did not suppress the following immunoprecipitation of the 51 kD a antigen with the APS I patient serum.
Karounos and Thomas [32] found reactivity against an RINm 5F cell membrane antigen of 52 kDa when analysing sera from non-obese diabetic (NOD) mice. Using a similar procedure, we tested sera from 10 prediabetic female N O D mice in parallel with sera from two APS I patients ( # 1 and # 3). Although two of the ten N O D mice sera reacted weakly against a 52 kDa protein, it migrated slower in the SDS-PAGE than the 51 kDa antigen recognized by the APS I patients (data not shown).
Recent evidence suggests that a considerable fraction of APS I patients eventually develop Type 1 Fig.6 (A,B) . APS I reactivity against the different isoforms of GAD. A: Fluorography of an SDS-PAGE of immunoprecipitates from psS]-methionine labelled lysates of COS cells transfected with recombinant GAD-65 or GAD-67. Sera from all six APS I patients were analysed in parallel with specific antisera NIMH-1440 and K2, a stiff-man syndrome (SMS) patient serum and a healthy blood donor serum (NHS). APS I patients # 1, # 2, # 4, # 5, # 6 reacted against GAD-65 as did the NIMH-1440 and the SMS patient serum. APS I patients # 1, # 2, and # 5, as well as K2 antiserum and serum from the SMS patient, reacted against GAD-67. B: Western blot analysis of lysates of COS cells transfected with recombinant GAD-65 or GAD-67. Sera from all six APS I patients were analysed in parallel with the specific antisera NIMH-1440 and K2, and sera from a patient with SMS and a healthy blood donor (NHS). GAD-65 was recognized by APS I patients # 1, # 2, # 4, # 5 and # 6, as well as by the NIMH-1440 antiserum and the SMS patient serum. GAD-67 was recognized by the sera of APS I patients # 1 and # 5 as well by the K2 antiserum and the SMS patient serum. Arrows in the left margin indicate approximate positions of GAD-67 and GAD-65. Molecular weight markers are indicated in the right margin diabetes in the course of their disease [9, 15] . The pattern of evolution towards beta-cell failure however, differs f r o m that observed in patients with classic Type 1 diabetes, and the courses are likely to reflect separate genetic as well as e n v i r o n m e n t a l influences on the susceptibility to islet cell damage. Possibly, longitudinal studies of A P S I patients following the diagnosis of their s y n d r o m e can help to identify pathogenetic events preceding the onset of Type i diabetes. In this study we show that the reactivity of A P S I sera against a m a j o r islet cell antigen, G A D , differ f r o m that of sera f r o m patients with classic Type 1 diabetes and that the A P S I sera also react against a novel islet cell 51 k D a antigen. Since the majority of proteins recognized as antigens in a u t o i m m u n e diseases are enzymes [33] with i m p o r t a n t roles in the physiology of the organs [4, 26, 27, 34] , we suggest that the novel 51 k D a antigen might be involved in an i m p o r t a n t function of the islets of Langerhans.
